Patents

UNITED STATES PATENTS:

  • Redmond, Gold, Kleber. Method of eliminating opiate withdrawal symptoms with clonidine in humans. Patent #: 4/312,878. Issued: January 26, 1982
  • Brompocriptine method of eliminating cocaine withdrawal. #731,102 and #791,188 (see Dackis and Gold, Lancet 1(8438)1151-1152, 1985
  • Method of eliminating amphetamine and cocaine withdrawal with dopamine agonists #20, 1941.2,1986. (Gold and Dackis Clin Ther 7(1):6-21, 1984)
  • Marker Detection Method and Apparatus to Monitor Drug Compliance #60/164,250, Filed November 8, 2000
  • Method and Apparatus for Detecting Illicit Substances #60/292,964 filed May 23, 2001
  • Methods and Apparatus for Therapeutic Drug Monitoring using Exhaled Breath #10/788,501 filed February 26, 2004
  • Novel Methods and Apparatus for Therapeutic Drug Monitoring Using Exhaled Breath # 10/788, 501, Filed February 26, 2004
  • Methods and Systems for Preventing Diversion of Prescription Drugs- #11/578,332, Filed September 20, 2004
  • System and Method for Monitoring Health Using Exhaled Breath – #11/301, 911, Filed December 13, 2005. Docket No. 10457-136CIP, UF#11973. Election filed in response to restriction requirement on March 4, 2010
  • Method and Apparatus for Detecting Environmental Smoke Exposure #7/052,468, Filed May 30, 2006
  • System and Method for Monitoring Health Using Exhaled Breath (Propofol Claims) #11/512, 856, Filed August 29, 2006
  • A Novel System for Monitoring Environmental Contamination from Controlled Substances U11458
  • Diagnosis and Treatment of Neurological Inflammation WO 2008/008819
  • System and method for monitoring health using exhaled breath # 20070167,853, Filed July 19, 2007
  • Devices and Methods for the Collection and Detection of Substances on Surfaces and Air # 60/971,451. Filed September 11, 2007
  • System and Method for Real-Time Diagnosis, Treatment, and Therapeutic Drug Monitoring # 20070258894 filed November 7, 2007
  • Methods and Systems for Preventing Diversion of Prescription Drugs #20080059226 filed March 6, 2008
  • Devices and Methods for the Collection and Detection of Substances (Gold MS, Martin DM, Gold ST, Goldberger BA, Rao A.) Serial No. 12/208,896; filed September 11, 2008. UF #-12604. US Patent # 8,414,846; issued April 9, 2013
  • Medication Adherence Monitoring System PCT/US08/054755; filed February 22 2008; Provisional application: US 60/891,085, filed 22 February 2007; Our docket No. 10457-132JP; UF# 12393; Patent Application Publication (Melker, Dennis, Batich, Gold), Pub No.: US 2010/0255598 AI, Pub. Date: Oct. 7, 2010
  • “Balclofen/Naltrexone Combination Therapy for suppressing Binge Eating of Palatable Food” UF#-13854; filed December 14, 2011, (Avena and Gold).
  • Compositions for Controlling Food Intake and Uses Therefor (Mark S. Gold and Nicole M. Avena). Patent # 9,610,285 B2. Issued April 4, 2017.

INTERNATIONAL PATENTS:

  • Method and Apparatus for Detecting Illicit Substances PCT/US02/161157, filed May 22, 2002
  • Method and Apparatus for Detecting Environmental Smoke Exposure PCT/US02/16153 filed May 22, 2002
  • System and Method for Real-Time Diagnosis, Treatment, and Therapeutic Drug Monitoring PCT/US05/06355, Filed March 17, 2005
  • Intelligent Drug and/or Fluid Delivery System to Optimizing Medicial Treatment or Therapy Using Pharmacodynamic and/or Pharmacokinetic Data. (Melker R)  International Application Number: PCT/US11/48083 EFS ID: 14967843
  • European Appln No. 06849923.5  System and Method for Monitoring Health Using Exhaled Breath (Melker, Dennis, Bjoraker, Gold) Our Docket No. 10457-135EP; SLS Docket No. 270C4EPO. UF#11973
  • Canadian Appln No. (not yet assigned) System and Method for Monitoring Health Using Exhaled Breath (Melker, Dennis, Bjoraker, Gold) Our Docket No. 10457-135CA; SLS Docket No. 270C4EPO. UF#11973
  • Medication Adherence Monitoring System. (Melker, Dennis, Batich, Gold) Application No: PCT/US 2008/054755 Application filing date: 2008/02/22; Date application made available for public inspection: 2008/8/28; Date on which patent was granted and issued: 2012/11/13. Canadian patent number: 2,678,969
  • Central Site Photoplethysmography, Medication Administration, and Safety. (Melker R, Dennis, Melker J, Rice, Hurley, Gold, Allen). International application no: PCT/US2011/046943 Application filing date: 08.08.2011 International Publication Number WO 2012/024106 A2 International Publication Date: 23.02.2012
Mentees Yale University School of Medicine
Professor Brian Fuerhlein MD, PhD. and Johns Hopkins Chris Hammond, MD, PhD. 
DEA Panel on Cocaine and Cocaine – Related Deaths
Mentee and Collaborator on Methamphetamine
Jean Lud Cadet, MD , NIDA Chief, Neurpharmacology 
Lifetime Achievement Award Presentation,
NYC, Chairman USC Dr. David Baron, DO & Kenneth Blum PhD.